| REGISTERED NUMBER: 08306196 (England and Wales) |
| IPULSE LIMITED |
| GROUP STRATEGIC REPORT, |
| REPORT OF THE DIRECTORS AND |
| CONSOLIDATED FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED |
| 31 DECEMBER 2025 |
| REGISTERED NUMBER: 08306196 (England and Wales) |
| IPULSE LIMITED |
| GROUP STRATEGIC REPORT, |
| REPORT OF THE DIRECTORS AND |
| CONSOLIDATED FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED |
| 31 DECEMBER 2025 |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| CONTENTS OF THE CONSOLIDATED FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| Page |
| Company Information | 1 |
| Group Strategic Report | 2 |
| Report of the Directors | 5 |
| Report of the Independent Auditors | 7 |
| Consolidated Income Statement | 10 |
| Consolidated Other Comprehensive Income | 11 |
| Consolidated Balance Sheet | 12 |
| Company Balance Sheet | 13 |
| Consolidated Statement of Changes in Equity | 14 |
| Company Statement of Changes in Equity | 15 |
| Consolidated Cash Flow Statement | 16 |
| Notes to the Consolidated Cash Flow Statement | 17 |
| Notes to the Consolidated Financial Statements | 18 |
| IPULSE LIMITED |
| COMPANY INFORMATION |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| DIRECTORS: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| AUDITORS: |
| Ground Floor Cardigan House |
| Castle Court |
| Swansea Enterprise Park |
| Swansea |
| SA7 9LA |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| GROUP STRATEGIC REPORT |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| The directors present their strategic report of the company and the group for the year ended 31 December 2025. |
| PRINCIPAL ACTIVITIES |
| The Group applies innovative expertise in skin and hair to energy-based products underpinned by research and clinical evidence. Its principal activity is the design, development, manufacture, and sale of intense pulsed light (IPL) devices for home-use hair removal. The Group sells its IPL products both as an Outsourced Design Manufacturer (ODM) to a single large customer, and internationally under its own brand SmoothSkin. |
| REVIEW OF BUSINESS |
| 2025 | 2024 |
| Turnover £'000 | 85,004 | 83,919 |
| Gross Profit Margin | 25% | 20% |
| Average Number of Employees | 321 | 286 |
| Both turnover and gross profit margin increased year-on-year, driven by higher sales volumes and cost optimisation respectively. The uplift contributed to significant increases in operating and net profit year on year, supported by greater profit efficiency. There was continued investment in key internal capabilities - particularly research, development, and clinical - supporting innovation across the entire skin wellness spectrum. The balance sheet shows an improved net assets position and an enhanced ratio of current assets to current liabilities. The Directors believe the Group is well positioned to pursue diverse opportunities and further optimise operations in line with customer demand. |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| GROUP STRATEGIC REPORT |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| PRINCIPAL RISKS AND UNCERTAINTIES |
| The Directors maintain robust risk management processes to minimise exposure to both identified and unforeseen risks, allowing focus on delivering strategic objectives. Principal risks that could impact performance or solvency are regularly reviewed and action taken to ensure effective risk-management. |
| Monitoring is continuous, via weekly and monthly scorecards and Key Performance Indicators. The Directors review developments in the economic, regulatory, and market landscape to identify potential risks and opportunities and adjust the business model as needed. The Group utilises financial instruments such as cash, trade debtors, and creditors to support operational financing. The following are the principal risks and uncertainties that could materially affect the Group's ability to achieve its strategy: |
| Liquidity Risk |
| The Group maintains a prudent approach to liquidity management, ensuring sufficient cash resources are available to meet operational needs and support growth opportunities. Interest and finance charges are minimised, and surplus cash is invested securely to preserve value and ensure ready access when required. |
| Credit Risk |
| The Group's principal financial assets are cash and trade receivables. Credit risk arises primarily from trade receivables and is managed through the use of customer credit limits based on payment history and external credit assessments. The Financial Controllers review debtor exposure regularly, including ageing profiles and collection performance, to mitigate concentration and default risk. |
| Trading Risks |
| (i) Customer Concentration |
| A significant portion of the Group's revenue is derived from a single customer under an ODM arrangement. Whilst a potential concentration risk, mitigation is via the Group's own-brand international IPL business and ongoing development of diverse revenue streams. |
| (ii) Regulatory Framework: |
| IPL hair removal devices are typically regulated as medical devices across major markets. The Group holds global regulatory certifications, reflecting its strong track record in compliance. While any future changes in regulatory frameworks could affect market access, the Group's in-house regulatory expertise ensures timely adaptation and continued compliance. |
| (iii) Economic climate: |
| A significant portion of the Group's trading activity is undertaken by a UK-based company and the Group reports in GBP. Although interest rates have begun to ease in 2025, they remain relatively high and lingering inflationary pressures continue to impact the UK economy. Exchange rate movements, particularly GBP/USD can significantly affect margin translation given that the majority of the Group's trading is denominated in USD. The Directors actively monitor economic conditions and regularly review pricing, procurement, investment plans, and hedge strategically to mitigate ongoing macroeconomic risk. |
| (iv) Disruption of Production / Supply Chain |
| Global supply chain disruptions remain a risk factor. The Group actively manages supplier relationships, lead times, and inventory levels, with contingency planning in place to minimise the impact of delays in raw materials or component availability. |
| Information Technology |
| The Group is highly dependent on secure and resilient IT systems. Risks include data loss, cyber threats, systems downtime, and the unauthorised access or use of confidential data. The Group has invested in its IT infrastructure, including robust backup protocols, system security measures, and business continuity planning. Ongoing enhancements are made to protect customer data and maintain compliance with data privacy regulations across all relevant jurisdictions. |
| Data Protection |
| While GDPR is now well-established, the Group recognises that data protection remains a dynamic area of regulatory focus. Processes are in place to ensure that data handling remains compliant with current laws and evolving regulatory expectations, supported by ongoing staff training and internal governance. |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| GROUP STRATEGIC REPORT |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| Health, Safety, and Environmental (HSE) Compliance |
| The Group maintains a comprehensive HSE policy aligned with applicable legislation and best practice. Health and safety obligations are monitored and reviewed regularly. Environmental considerations are embedded into operations, with attention to sustainable practices. |
| Product Quality and Accreditation |
| The Group holds internationally recognised quality and regulatory certifications relevant to the development and manufacture of IPL devices, including ISO 13485 (covering US FDA and Health Canada), MDSAP, and Korean MFDS K-GMP. These accreditations underpin product quality, regulatory compliance, and customer assurance across global markets. |
| SECTION 172(1) STATEMENT |
| The directors are well aware of their duty under s172 of the Companies Act 2006 to act in the way which they consider, in good faith, would most likely promote the success of the group for the benefit of its members as a whole and, in doing so, to have regards to the following: - |
| - | The likely long-term consequences of any decision; |
| - | The interest of the group's employees; |
| - | The need to foster the group's business relationships with suppliers, customers and other stakeholders; |
| - | The impact of the group's operations on the community and the environment; and |
| - | Desirability of the group maintaining a reputation for high standards of business conduct. |
| The Directors embed these considerations in decision-making through the Company's business strategy, culture, governance framework, and stakeholder engagement practices. Major stakeholders include employees, customers, suppliers, and shareholders. Their interests are regularly considered as part of discussions and strategic decisions. |
| The Directors promote a culture of high ethical and regulatory standards and recognise that building strong and enduring relationships with stakeholders supports long-term sustainable success. |
| ON BEHALF OF THE BOARD: |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| REPORT OF THE DIRECTORS |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| The directors present their report with the financial statements of the company and the group for the year ended 31 December 2025. |
| DIVIDENDS |
| No dividends will be distributed for the year ended 31 December 2025. |
| RESEARCH AND DEVELOPMENT |
| The Company continues to invest in research and development to enhance its product offering. The Directors view this as integral to the Company's long-term competitiveness. |
| EVENTS SINCE THE END OF THE YEAR |
| Information relating to events since the end of the year is given in the notes to the financial statements. |
| DIRECTORS |
| The directors shown below have held office during the whole of the period from 1 January 2025 to the date of this report. |
| POLITICAL DONATIONS AND EXPENDITURE |
| The group made no political donations and incurred no political expenditure during the year. |
| STATEMENT OF GOING CONCERN |
| The Directors have considered the financial position of the Company and its forecast performance and are satisfied that it is appropriate to adopt the going concern basis in preparing the financial statements. In forming this view, the Directors have taken into account all relevant information available to the date of approval of the financial statements, including current trading, cash flow forecasts, and available financing facilities. |
| ENGAGEMENT WITH EMPLOYEES |
| The Company recognises that employee engagement is fundamental to its culture and long-term success. The Directors place high importance on workforce wellbeing and are committed to supporting employees' development, motivation, and inclusion. |
| Employees are kept informed of matters affecting them and the Company's performance through a combination of formal updates and informal communication. The Company maintains an open approach to feedback and engagement at all levels. |
| The Company is committed to fair pay and benefits and operates as an equal opportunities employer, upholding the principle of equality in recruitment, development, and reward. |
| ENGAGEMENT WITH SUPPLIERS, CUSTOMERS AND OTHERS |
| Customers |
| Customer relationships are central to the Company's commercial success. The Company maintains regular engagement with its customers to ensure service expectations are met and to support long-term partnership. |
| Suppliers |
| The Company works with a network of suppliers who are essential to delivering continuity and quality of service. It aims to act fairly and transparently in its dealings and seeks to build collaborative relationships that reflect the Company's values. |
| Shareholders |
| The Company is privately owned and the Directors are committed to acting in the best interests of its shareholders. The Directors ensure that relevant information is communicated to shareholders in a timely, transparent, and responsible manner. |
| STREAMLINED ENERGY AND CARBON REPORTING |
| In accordance with the Companies (Directors' Report) and Limited Liability Partnerships (Energy and Carbon Report) Regulations 2018, disclosure of UK energy and Greenhouse Gas emissions is as follows: |
| 2025 | 2024 |
| Total Energy Consumption | KWh | kWh |
| 1,373,637 | 1,277,147 |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| REPORT OF THE DIRECTORS |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| GHG Emissions CO2 equivalent | 2025 | 2024 |
| metric tonnes | metric tonnes |
| Natural gas (Scope 1) | 84.1 | 79.6 |
| Purchased Electricity (Scope 2) | 156.4 | 165.1 |
| Transport (Scope 1 & 3 combined) | 11.5 | 10.8 |
| Total gross CO2e emissions | 252 | 255.5 |
| Intensity Ratio |
| metric tonnes CO2e per £100,000 of Turnover | 0.33 | 0.33 |
| Methodology |
| The adopted methodology used is based on the Greenhouse Gas Protocol Corporate Reporting Standard reporting on equivalent CO2 emissions from organisational boundary. Information has been gathered in the same format as for compliance with the ESOS Regulations, for Scope 1 & 2 emissions, collated into kWh for all directly owned or operated corresponding UK based operations (i.e. the organisational boundary). |
| These have been converted to equivalent tonnes of carbon dioxide (tCO2e) using the published UK Government GHG Conversion Factors for Company Reporting for 2025. |
| Energy efficiency |
| No energy efficiency measures were implemented during the reporting period. HVAC, lighting, and insulation considerations were explored for implementation in future period |
| STATEMENT OF DIRECTORS' RESPONSIBILITIES |
| The directors are responsible for preparing the Group Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations. |
| Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the group and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to: |
| - | select suitable accounting policies and then apply them consistently; |
| - | make judgements and accounting estimates that are reasonable and prudent; |
| - | state whether applicable accounting standards have been followed, subject to any material departures disclosed and explained in the financial statements; |
| - | prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. |
| The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's and the group's transactions and disclose with reasonable accuracy at any time the financial position of the company and the group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. |
| STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS |
| So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the group's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the group's auditors are aware of that information. |
| ON BEHALF OF THE BOARD: |
| REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF |
| IPULSE LIMITED |
| Opinion |
| We have audited the financial statements of IPulse Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 December 2025 which comprise the Consolidated Income Statement, Consolidated Other Comprehensive Income, Consolidated Balance Sheet, Company Balance Sheet, Consolidated Statement of Changes in Equity, Company Statement of Changes in Equity, Consolidated Cash Flow Statement and Notes to the Consolidated Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice). |
| In our opinion the financial statements: |
| - | give a true and fair view of the state of the group's and of the parent company affairs as at 31 December 2025 and of the group's profit for the year then ended; |
| - | have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and |
| - | have been prepared in accordance with the requirements of the Companies Act 2006. |
| Basis for opinion |
| We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. |
| Conclusions relating to going concern |
| In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. |
| Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. |
| Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report. |
| Other information |
| The directors are responsible for the other information. The other information comprises the information in the Group Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon. |
| Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. |
| In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard. |
| Opinions on other matters prescribed by the Companies Act 2006 |
| In our opinion, based on the work undertaken in the course of the audit: |
| - | the information given in the Group Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and |
| - | the Group Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements. |
| Matters on which we are required to report by exception |
| In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group Strategic Report or the Report of the Directors. |
| We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion: |
| - | adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or |
| - | the parent company financial statements are not in agreement with the accounting records and returns; or |
| - | certain disclosures of directors' remuneration specified by law are not made; or |
| - | we have not received all the information and explanations we require for our audit. |
| REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF |
| IPULSE LIMITED |
| Responsibilities of directors |
| As explained more fully in the Statement of Directors' Responsibilities set out on page six, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. |
| In preparing the financial statements, the directors are responsible for assessing the group's and the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or the parent company or to cease operations, or have no realistic alternative but to do so. |
| Auditors' responsibilities for the audit of the financial statements |
| Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. |
| The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below: |
| Extent to which the audit was considered capable of detecting irregularities, including fraud |
| We identify and assess the risks of material misstatement of the Financial Statements, whether due to fraud or error, and then, design and perform audit procedures responsive to those risks, including obtaining audit evidence that is sufficient and appropriate to provide a basis for our opinion. |
| We discussed our audit independence complying with the Revised Ethical Standard 2024 with the engagement team members whilst planning the audit and continually monitored our independence throughout the process. |
| Identifying and assessing potential risks related to irregularities. |
| In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, our procedures included the following: |
| - | enquiring of management, including obtaining and reviewing supporting documentation, concerning the Group's policies and procedures relating to: |
| - | identifying, evaluating and complying with laws and regulations and whether they were aware of any instances of non-compliance; |
| - | detecting and responding to the risks of fraud and whether they have knowledge of any actual. suspected or alleged fraud; |
| - | the internal controls established to mitigate risks related to fraud or non-compliance with laws and regulations; |
| - | discussing among the engagement team how and where fraud might occur in the Financial Statements and any potential indicators of fraud. As part of this discussion, we identified potential for fraud in the following areas; |
| - | Assumptions used for valuing work in progress at the year end, and; |
| - | Potential for deferring income already earned at the year end. |
| - | obtaining an understanding of the legal and regulatory frameworks that the Group operates in, focusing on those laws and regulations that had a direct effect on the Financial Statements or that had a fundamental effect on the operations of the Group, The key laws and regulations we considered in this context included the UK Companies Act and relevant tax legislation. |
| Audit response to risks identified |
| In addition to the above, our procedures to respond to risks identified included the following: |
| - | reviewing the financial statement disclosures and testing to supporting documentation to assess compliance with relevant laws and regulations; |
| - | enquiring of management concerning actual and potential litigation and claims; performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud; |
| - | reading minutes of meetings of those charged with governance and reviewing correspondence with HMRC; and |
| - | in addressing the risk of fraud through management override of controls, testing the appropriateness of journal entries and other adjustments; |
| - | assessing whether the judgements made in making accounting estimates are indicative of a potential bias; and |
| - | evaluating the business rationale of any significant transactions that are unusual or outside the normal course of business. |
| We also communicated relevant identified laws and regulations and potential fraud risks to all engagement team members and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit. |
| A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors. |
| REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF |
| IPULSE LIMITED |
| Use of our report |
| This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed. |
| for and on behalf of |
| Ground Floor Cardigan House |
| Castle Court |
| Swansea Enterprise Park |
| Swansea |
| SA7 9LA |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| CONSOLIDATED |
| INCOME STATEMENT |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 2025 | 2024 |
| Notes | £ | £ |
| TURNOVER | 4 | 85,004,120 | 83,918,958 |
| Cost of sales | 63,646,645 | 67,280,076 |
| GROSS PROFIT | 21,357,475 | 16,638,882 |
| Administrative expenses | 17,090,498 | 16,294,469 |
| 4,266,977 | 344,413 |
| Other operating income | 2,363,096 | 1,289,493 |
| OPERATING PROFIT | 6 | 6,630,073 | 1,633,906 |
| Interest receivable and similar income | 108 | 145 |
| 6,630,181 | 1,634,051 |
| Interest payable and similar expenses | 7 | 580,104 | 555,138 |
| PROFIT BEFORE TAXATION | 6,050,077 | 1,078,913 |
| Tax on profit | 8 | 559,031 | 522,833 |
| PROFIT FOR THE FINANCIAL YEAR |
| Profit attributable to: |
| Owners of the parent | 5,491,046 | 556,080 |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| CONSOLIDATED |
| OTHER COMPREHENSIVE INCOME |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 2025 | 2024 |
| Notes | £ | £ |
| PROFIT FOR THE YEAR | 5,491,046 | 556,080 |
| OTHER COMPREHENSIVE INCOME | - | - |
| TOTAL COMPREHENSIVE INCOME FOR THE YEAR |
5,491,046 |
556,080 |
| Total comprehensive income attributable to: |
| Owners of the parent | 5,491,046 | 556,080 |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| CONSOLIDATED BALANCE SHEET |
| 31 DECEMBER 2025 |
| 2025 | 2024 |
| Notes | £ | £ | £ | £ |
| FIXED ASSETS |
| Intangible assets | 10 | 1,753,837 | 1,828,598 |
| Tangible assets | 11 | 4,208,674 | 4,961,156 |
| Investments | 12 | - | - |
| 5,962,511 | 6,789,754 |
| CURRENT ASSETS |
| Stocks | 13 | 20,968,731 | 17,678,392 |
| Debtors | 14 | 19,944,534 | 13,930,315 |
| Cash at bank and in hand | 1,605,138 | 920,209 |
| 42,518,403 | 32,528,916 |
| CREDITORS |
| Amounts falling due within one year | 15 | 19,236,895 | 16,004,992 |
| NET CURRENT ASSETS | 23,281,508 | 16,523,924 |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
29,244,019 |
23,313,678 |
| CREDITORS |
| Amounts falling due after more than one year |
16 |
(743,714 |
) |
(492,859 |
) |
| PROVISIONS FOR LIABILITIES | 18 | (619,224 | ) | (315,370 | ) |
| NET ASSETS | 27,881,081 | 22,505,449 |
| CAPITAL AND RESERVES |
| Called up share capital | 19 | 52,361 | 52,211 |
| Share premium | 20 | 1,398,966 | 1,398,966 |
| Capital redemption reserve | 20 | 1,719 | 1,719 |
| Share option reserve | 20 | 501,845 | 617,409 |
| EBT reserve | 20 | (1,075,000 | ) | (1,075,000 | ) |
| Retained earnings | 20 | 27,001,190 | 21,510,144 |
| SHAREHOLDERS' FUNDS | 27,881,081 | 22,505,449 |
| The financial statements were approved by the Board of Directors and authorised for issue on 13 August 2026 and were signed on its behalf by: |
| R Van Rozen - Director |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| COMPANY BALANCE SHEET |
| 31 DECEMBER 2025 |
| 2025 | 2024 |
| Notes | £ | £ | £ | £ |
| FIXED ASSETS |
| Intangible assets | 10 |
| Tangible assets | 11 |
| Investments | 12 |
| CURRENT ASSETS |
| Debtors | 14 |
| Cash at bank |
| CREDITORS |
| Amounts falling due within one year | 15 |
| NET CURRENT ASSETS |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CAPITAL AND RESERVES |
| Called up share capital | 19 |
| Share premium | 20 |
| Capital redemption reserve | 20 |
| Share option reserve | 20 |
| EBT reserve | 20 | ( |
) | ( |
) |
| Retained earnings | 20 |
| SHAREHOLDERS' FUNDS |
| Company's profit for the financial year | 90,772 | 4,092,239 |
| The financial statements were approved by the Board of Directors and authorised for issue on |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| CONSOLIDATED STATEMENT OF CHANGES IN EQUITY |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| Called up |
| share | Retained | Share |
| capital | earnings | premium |
| £ | £ | £ |
| Balance at 1 January 2024 | 49,333 | 20,954,064 | 1,398,966 |
| Changes in equity |
| Issue of share capital | 2,878 | - | - |
| Total comprehensive income | - | 556,080 | - |
| Balance at 31 December 2024 | 52,211 | 21,510,144 | 1,398,966 |
| Changes in equity |
| Increase in share capital | 150 | - | - |
| Total comprehensive income | - | 5,491,046 | - |
| Balance at 31 December 2025 | 52,361 | 27,001,190 | 1,398,966 |
| Capital | Share |
| redemption | option | EBT | Total |
| reserve | reserve | reserve | equity |
| £ | £ | £ | £ |
| Balance at 1 January 2024 | 1,719 | 617,409 | (1,075,000 | ) | 21,946,491 |
| Changes in equity |
| Issue of share capital | - | - | - | 2,878 |
| Total comprehensive income | - | - | - | 556,080 |
| Balance at 31 December 2024 | 1,719 | 617,409 | (1,075,000 | ) | 22,505,449 |
| Changes in equity |
| Increase in share capital | - | - | - | 150 |
| Share option fair value | - | (115,564 | ) | - | (115,564 | ) |
| Total comprehensive income | - | - | - | 5,491,046 |
| Balance at 31 December 2025 | 1,719 | 501,845 | (1,075,000 | ) | 27,881,081 |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| COMPANY STATEMENT OF CHANGES IN EQUITY |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| Called up |
| share | Retained | Share |
| capital | earnings | premium |
| £ | £ | £ |
| Balance at 1 January 2024 | ( |
) |
| Changes in equity |
| Issue of share capital | - |
| Total comprehensive income | - | - |
| Balance at 31 December 2024 |
| Changes in equity |
| Increase in share capital | 150 | - | - |
| Total comprehensive income | - | - |
| Balance at 31 December 2025 |
| Capital | Share |
| redemption | option | EBT | Total |
| reserve | reserve | reserve | equity |
| £ | £ | £ | £ |
| Balance at 1 January 2024 | ( |
) |
| Changes in equity |
| Issue of share capital | - | - | - |
| Total comprehensive income |
| Balance at 31 December 2024 | ( |
) |
| Changes in equity |
| Increase in share capital | - | - | - | 150 |
| Share option fair value | - | (115,564 | ) | - | (115,564 | ) |
| Total comprehensive income |
| Balance at 31 December 2025 | ( |
) |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| CONSOLIDATED CASH FLOW STATEMENT |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 2025 | 2024 |
| Notes | £ | £ |
| Cash flows from operating activities |
| Cash generated from operations | 1 | 2,979,090 | 2,854,337 |
| Interest paid | (580,104 | ) | (555,138 | ) |
| Reversal of share based payment expense | (115,564 | ) | - |
| Tax paid | - | 405 |
| Net cash from operating activities | 2,283,422 | 2,299,604 |
| Cash flows from investing activities |
| Purchase of intangible fixed assets | (656,957 | ) | (901,328 | ) |
| Purchase of tangible fixed assets | (1,982,905 | ) | (1,317,055 | ) |
| Sale of intangible fixed assets | 4,056 | - |
| Sale of tangible fixed assets | 350,052 | 47,597 |
| Interest received | 108 | 145 |
| Capital contributions | 687,003 | 154,390 |
| Net cash from investing activities | (1,598,643 | ) | (2,016,251 | ) |
| Cash flows from financing activities |
| Share issue | 150 | 2,878 |
| Net cash from financing activities | 150 | 2,878 |
| Increase in cash and cash equivalents | 684,929 | 286,231 |
| Cash and cash equivalents at beginning of year |
2 |
920,209 |
633,978 |
| Cash and cash equivalents at end of year | 2 | 1,605,138 | 920,209 |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| NOTES TO THE CONSOLIDATED CASH FLOW STATEMENT |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 1. | RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS |
| 2025 | 2024 |
| £ | £ |
| Profit before taxation | 6,050,077 | 1,078,913 |
| Depreciation charges | 3,113,455 | 3,266,862 |
| Loss/(profit) on disposal of fixed assets | 538 | (2,211 | ) |
| Movement in provisions | 303,854 | (495,171 | ) |
| Deferred capital contributions | (782,529 | ) | (973,147 | ) |
| Finance costs | 580,104 | 555,138 |
| Finance income | (108 | ) | (145 | ) |
| 9,265,391 | 3,430,239 |
| Increase in stocks | (3,290,339 | ) | (385,042 | ) |
| (Increase)/decrease in trade and other debtors | (6,574,232 | ) | 205,499 |
| Increase/(decrease) in trade and other creditors | 3,578,270 | (396,359 | ) |
| Cash generated from operations | 2,979,090 | 2,854,337 |
| 2. | CASH AND CASH EQUIVALENTS |
| The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts: |
| Year ended 31 December 2025 |
| 31.12.25 | 1.1.25 |
| £ | £ |
| Cash and cash equivalents | 1,605,138 | 920,209 |
| Year ended 31 December 2024 |
| 31.12.24 | 1.1.24 |
| £ | £ |
| Cash and cash equivalents | 920,209 | 633,978 |
| 3. | ANALYSIS OF CHANGES IN NET FUNDS |
| At 1.1.25 | Cash flow | At 31.12.25 |
| £ | £ | £ |
| Net cash |
| Cash at bank and in hand | 920,209 | 684,929 | 1,605,138 |
| 920,209 | 684,929 | 1,605,138 |
| Total | 920,209 | 684,929 | 1,605,138 |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 1. | STATUTORY INFORMATION |
| IPulse Limited is a |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| The company includes the iPulse Employee Benefit Trust (EBT) in its financial statements. The EBT is classified as an intermediate payment arrangement and the assets and liabilities of the EBT are recognised as assets and liabilities of the sponsoring entity iPulse Limited. Included within the financial statements is the EBT bank balance plus the shares and reserves held by the trust. |
| Basis of consolidation |
| The consolidated financial statements include the company and its subsidiary undertakings and have been prepared using the acquisition method of accounting. |
| All material companies, which are more than 50% controlled, either directly or indirectly, are fully consolidated. Control is presumed to exist where more than half of a subsidiary's voting rights are controlled by the parent company, or where the parent company has the right to remove or appoint a majority of a subsidiary's board of directors or has entered into an agreement with the other shareholders or partners of a subsidiary. Minority interest is shown under the appropriate heading in the consolidated balance sheet and profit and loss account. |
| The financial statements of the subsidiaries of all Group entities that have a currency different from £ are translated into £ as follows. |
| Assets and liabilities, except for capital and reserves, for each balance sheet items presented are translated at the rate prevailing at the balance sheet date. Capital and reserves are converted at the historical rate of exchange. Income and expenses for each consolidated profit and loss account are translated at average exchange rates. |
| The financial statements of the subsidiaries used in the preparation of the consolidated financial statements are prepared for the same reporting period as the parent company and are based on consistent accounting policies or where appropriate accounting policies for subsidiaries have been changed to ensure consistency with the policies adopted by the Group. The results of subsidiaries acquired or disposed of during the period are included in the consolidated financial statements from the effective date of acquisition up to the effective date of disposal, as appropriate. |
| Where a subsidiary year end differs to that of the parent, the consolidated financial statements are made up from interim financial statements prepared by the subsidiary at the reporting date. |
| Intra-group balances and any unrealised gains and losses or income and expenses arising from intra-group transactions, are eliminated in preparing the consolidated financial statements. |
| Related party exemption |
| The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group. |
| Transactions between group entities which have been eliminated on consolidation are not disclosed within the financial statements. |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 2. | ACCOUNTING POLICIES - continued |
| Turnover |
| Turnover comprises revenue recognised by the company in respect of goods supplied during the year, exclusive of Value Added Tax and trade discounts. |
| Turnover in respect of product is recognised when the company has performed its obligations in exchange for the right to consideration. This is ordinarily deemed to be at the point of despatch of the goods to the customer. |
| Interest income is recognised in the Statement of Comprehensive Income using the effective interest method. |
| Intangible assets |
| Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses. |
| Tangible fixed assets |
| Improvements to property | - |
| Plant and Machinery | - |
| Fixtures and fittings | - |
| Motor vehicles | - |
| Computer equipment | - |
| Tangible fixed assets are stated at cost less accumulated depreciation and accumulated impairment losses. Such cost includes costs directly attributable to making the asset capable of operating as intended. |
| Impairment of fixed assets |
| The company performs impairment testing where there are any indicators of impairment. Impairment is calculated as the difference between the carrying value and the recoverable value of the asset. Recoverable value is the higher of net realisable value and estimated value in use at the date the impairment loss is recognised. Value in use represents the present value of expected future discounted cash flows. If incurred, impairment is recognised immediately in the income statement. |
| Where an impairment loss subsequently reverses, the carrying value of the asset is increased to the revised estimate of the recoverable amount, but so that the increased carrying value does not exceed the carrying value that would have been determined if no impairment loss had been recognised for the asset in prior years. A reversal of an impairment loss is recognised immediately as a credit to the income statement. |
| Fixed asset investments |
| Fixed asset investments are valued at fair value unless fair value cannot be measured reliably, in which case investments are valued at cost less impairment. |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 2. | ACCOUNTING POLICIES - continued |
| Stocks |
| Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving stocks. Cost includes all direct costs and, where required, an appropriate proportion of fixed and variable overheads. In general, cost is determined on a first in first out basis. |
| Stock is reviewed at each reporting date to determine whether there is any indication of impairment. |
| Debtors |
| Short term trade debtors are measured at transaction price, less any impairment. A provision for impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due. |
| Cash and cash equivalent |
| Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value. |
| In the statement of cash flows, cash and cash equivalents are shown in net of bank overdrafts that are repayable on demand and form an integral part of the Company's cash management. |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 2. | ACCOUNTING POLICIES - continued |
| Financial instruments |
| The group enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities such as trade and other receivables and payables, amounts due to and from related parties. |
| Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. |
| Debt instruments like loans and other receivables and payables are initially measured at present value of the future payments and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade payables or receivables, are measured, initially and subsequently, at the undiscounted amount of cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or financed at a rate of interest that is not a market rate or in case of an outright short-term loan not at market rate, the financial asset or liability is measured, initially and subsequently, at the present value of future payments discounted at a market rate of interest for a similar debt instrument. |
| Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in profit or loss. For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying value and the present value of estimated cash flows discounted at the assets original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract. For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and the best estimate, which is an approximation, of the amount that the group would receive for the asset if it were to be sold at the reporting date. |
| Financial assets and liabilities are offset and the net amount recognised in the balance sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. At each reporting date non-financial assets not carried at fair value, such as property, plant and equipment are reviewed to determine whether there is an indication that an asset may be impaired. If there is an indication of possible impairment, the recoverable amount of any asset or group of related assets, which is the higher of value in use and the fair value less costs to sell, is estimated and compared with its carrying amount. If the recoverable amount is lower, the carrying amount of the asset is reduced to its recoverable amount and an impairment loss is recognised immediately in profit or loss. |
| If an impairment loss is subsequently reversed, the carrying amount of the asset or group of related assets is increased to the revised estimate of its recoverable amount, but not to exceed the amount that would have been determined had no impairment loss been recognised for the asset or group of related assets in prior periods. A reversal of an impairment loss is recognised immediately in profit or loss. |
| Creditors |
| Short term creditors are measured at the transaction price. Bank loans are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method. |
| Provisions for liabilities |
| Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of the obligation. |
| Deferred Income |
| Contributions received towards development costs are recognised in the period that development expenditure is incurred. Capital contributions are initially recognised as deferred income on the balance sheet and credited to the profit and loss account by instalments on a basis consistent with the depreciation policy of the relevant asset, as adjusted for any impairment. |
| Warranty Provision |
| The company recognises a provision for warranty cost; which is valid for between 2 and 5 years depending on the product sold. A range of 2 - 20% of turnover is as provided. Once the product is 2->5 years old the warranty provision is released. |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 2. | ACCOUNTING POLICIES - continued |
| Taxation |
| Taxation for the year comprises current and deferred tax. Tax is recognised in the Consolidated Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
| Current or deferred taxation assets and liabilities are not discounted. |
| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
| Deferred tax |
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
| External research and development |
| Development costs are capitalised within intangible assets where they can be identified with a specific product or project anticipated to produce future benefits, and are amortised on the straight line basis the anticipated life of the benefits arising from the completed product or project, which typically is deemed to be 5 years. |
| Deferred research and development costs are reviewed annually, and where future benefits are deemed to have ceased or to be in doubt, the balance of any related research and development is written off to the income statement. Expenditure on product research and development is written off to the income statement in the year in which it is incurred. |
| R&D tax credits are recognised on an accruals basis and are included as an income tax credit under current assets. |
| Foreign currencies |
| Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling using a monthly average exchange rate. If exchange rates fluctuate significantly in the month foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result. |
| Pension costs and other post-retirement benefits |
| The group operates a defined contribution pension scheme. Contributions payable to the group's pension scheme are charged to profit or loss in the period to which they relate. |
| Share-based payments |
| The cost of equity-settled transactions with employees is measured by reference to the fair value of the equity instruments granted at the date at which they are granted and is recognised as an expense over the vesting period, which ends on the date on which the relevant employees become fully entitled to the award. |
| No expense is recognised for awards that do not ultimately vest, except for awards where vesting is conditional upon a market or non vesting condition, which are treated as vesting irrespective of whether or not the market or non vesting condition is satisfied, provided that all other performance conditions are satisfied. |
| The financial effect of awards by the parent company of options over its equity shares to the employees of subsidiary undertakings are recognised by the parent company in its individual financial statements. |
| Capital redemption reserve |
| Where shares are redeemed or purchased wholly out of profits available for distribution, a sum equal to the nominal value of the shares is transferred to the capital redemption reserve. |
| Functional and presentation currency |
| The group's functional and presentation currency is pounds sterling. |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 3. | CRITICAL ACCOUNTING JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY |
| The preparation of the financial statement requires management to make judgement, estimates and assumptions that affect the application of policies and reported amounts of assets and liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making the judgements about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates. |
| Warranty Returns Provision |
| The group provides warranty coverage on our products that varies per customer. The estimated warranty costs are accounted for by accruing these costs for each product upon recognition of the sale. The estimated warranty costs are based on the cost of the product and the historical level of returns received. Actual results may vary from these estimates but they are reviewed on an ongoing basis. |
| Useful lives of assets |
| Tangible assets are depreciated over their estimated useful lives of 5 years, they are stated at cost less accumulated depreciation. Tangible assets are reviewed periodically, and where any asset is no longer used by the group the balance is written off to the income statement. |
| Intangible assets are amortised over their estimated useful life of 5 years. They are both stated at cost less accumulated amortisation.Intangible assets are reviewed annually, and where future benefits are deemed to have ceased or to be in doubt, the balance is written off to the income statement. |
| 4. | TURNOVER |
| The turnover and profit before taxation are attributable to the one principal activity of the company. |
| The group supplies various markets other than just in the UK, the disclosure of which would be seriously prejudicial to the interests of the group and therefore will not be disclosed. |
| 5. | EMPLOYEES AND DIRECTORS |
| 2025 | 2024 |
| £ | £ |
| Wages and salaries | 10,714,764 | 9,511,003 |
| Social security costs | 1,616,251 | 1,162,597 |
| Other pension costs | 489,192 | 449,238 |
| 12,820,207 | 11,122,838 |
| The average number of employees during the year was as follows: |
| 2025 | 2024 |
| Clinical, research & development | 50 | 41 |
| CEO & senior management | 15 | 15 |
| Finance & HR | 16 | 14 |
| Operations, quality & factory | 223 | 191 |
| Sales & marketing | 17 | 15 |
| Included in creditors are pension contributions of £184,069 (2024: £99,312). |
| 2025 | 2024 |
| £ | £ |
| Directors' remuneration | 597,016 | 572,025 |
| Directors' pension contributions to money purchase schemes | 51,366 | 38,070 |
| The number of directors to whom retirement benefits were accruing was as follows: |
| Money purchase schemes | 1 | 1 |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 5. | EMPLOYEES AND DIRECTORS - continued |
| Information regarding the highest paid director is as follows: |
| 2025 | 2024 |
| £ | £ |
| Emoluments etc | 507,016 | 482,025 |
| Pension contributions to money purchase schemes | 51,366 | 38,070 |
| 6. | OPERATING PROFIT |
| The operating profit is stated after charging/(crediting): |
| 2025 | 2024 |
| £ | £ |
| Depreciation - owned assets | 2,384,797 | 2,585,885 |
| Loss/(profit) on disposal of fixed assets | 538 | (2,211 | ) |
| Patents and licences amortisation | 57,032 | 29,764 |
| Development costs amortisation | 613,106 | 600,702 |
| Computer software amortisation | 57,524 | 51,281 |
| Auditors' remuneration | 36,518 | 17,157 |
| Auditors' remuneration for non audit work | 25,707 | 29,113 |
| Foreign exchange differences | 353,444 | (628,377 | ) |
| Research & development expenditure | 1,829,337 | 1,764,459 |
| 7. | INTEREST PAYABLE AND SIMILAR EXPENSES |
| 2025 | 2024 |
| £ | £ |
| Bank loan interest | 571,915 | 548,159 |
| Other Interest | 8,189 | 6,979 |
| 580,104 | 555,138 |
| 8. | TAXATION |
| Analysis of the tax charge |
| The tax charge on the profit for the year was as follows: |
| 2025 | 2024 |
| £ | £ |
| Deferred tax | 559,031 | 522,833 |
| Tax on profit | 559,031 | 522,833 |
| Reconciliation of total tax charge included in profit and loss |
| The tax assessed for the year is lower than the standard rate of corporation tax in the UK. The difference is explained below: |
| 2025 | 2024 |
| £ | £ |
| Profit before tax | 6,050,077 | 1,078,913 |
| Profit multiplied by the standard rate of corporation tax in the UK of 25 % (2024 - 25 %) |
1,512,519 |
269,728 |
| Effects of: |
| Expenses not deductible for tax purposes | (337,912 | ) | (456,405 | ) |
| Income not taxable for tax purposes | (524,109 | ) | - |
| Utilisation of tax losses | - | 1,094,661 |
| Adjustments to tax charge in respect of previous periods | - | (5,791 | ) |
| R&D deduction | (91,467 | ) | (379,360 | ) |
| disallowed |
| Total tax charge | 559,031 | 522,833 |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 8. | TAXATION - continued |
| Factors that may affect future current and total tax charges |
| The deferred tax assets/liabilities at 31 December 2025 have been calculated at the rate of 25% (2024: 25%). |
| 9. | INDIVIDUAL INCOME STATEMENT |
| As permitted by Section 408 of the Companies Act 2006, the Income Statement of the parent company is not presented as part of these financial statements. |
| 10. | INTANGIBLE FIXED ASSETS |
| Group |
| Patents |
| and | Development | Computer |
| licences | costs | software | Totals |
| £ | £ | £ | £ |
| COST |
| At 1 January 2025 | 362,398 | 5,174,441 | 261,353 | 5,798,192 |
| Additions | 169,548 | 428,902 | 58,507 | 656,957 |
| Disposals | - | (5,406 | ) | - | (5,406 | ) |
| At 31 December 2025 | 531,946 | 5,597,937 | 319,860 | 6,449,743 |
| AMORTISATION |
| At 1 January 2025 | 226,689 | 3,564,249 | 178,656 | 3,969,594 |
| Amortisation for year | 57,032 | 613,106 | 57,524 | 727,662 |
| Eliminated on disposal | - | (1,350 | ) | - | (1,350 | ) |
| At 31 December 2025 | 283,721 | 4,176,005 | 236,180 | 4,695,906 |
| NET BOOK VALUE |
| At 31 December 2025 | 248,225 | 1,421,932 | 83,680 | 1,753,837 |
| At 31 December 2024 | 135,709 | 1,610,192 | 82,697 | 1,828,598 |
| Company |
| Patents |
| and |
| licences |
| £ |
| COST |
| At 1 January 2025 |
| Additions |
| At 31 December 2025 |
| AMORTISATION |
| At 1 January 2025 |
| Amortisation for year |
| At 31 December 2025 |
| NET BOOK VALUE |
| At 31 December 2025 |
| At 31 December 2024 |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 11. | TANGIBLE FIXED ASSETS |
| Group |
| Improvements | Fixtures |
| to | Plant and | and |
| property | Machinery | fittings |
| £ | £ | £ |
| COST |
| At 1 January 2025 | 4,687,831 | 11,411,961 | 367,123 |
| Additions | 182,425 | 1,501,618 | 120,360 |
| Disposals | (89,740 | ) | (270,171 | ) | (42,871 | ) |
| At 31 December 2025 | 4,780,516 | 12,643,408 | 444,612 |
| DEPRECIATION |
| At 1 January 2025 | 3,373,425 | 8,075,066 | 239,775 |
| Charge for year | 569,593 | 1,640,753 | 51,759 |
| Eliminated on disposal | (5,111 | ) | (47,595 | ) | (39 | ) |
| At 31 December 2025 | 3,937,907 | 9,668,224 | 291,495 |
| NET BOOK VALUE |
| At 31 December 2025 | 842,609 | 2,975,184 | 153,117 |
| At 31 December 2024 | 1,314,406 | 3,336,895 | 127,348 |
| Motor | Computer |
| vehicles | equipment | Totals |
| £ | £ | £ |
| COST |
| At 1 January 2025 | 18,944 | 1,041,330 | 17,527,189 |
| Additions | - | 178,502 | 1,982,905 |
| Disposals | - | (1,963 | ) | (404,745 | ) |
| At 31 December 2025 | 18,944 | 1,217,869 | 19,105,349 |
| DEPRECIATION |
| At 1 January 2025 | 4,737 | 873,030 | 12,566,033 |
| Charge for year | 3,789 | 118,903 | 2,384,797 |
| Eliminated on disposal | - | (1,410 | ) | (54,155 | ) |
| At 31 December 2025 | 8,526 | 990,523 | 14,896,675 |
| NET BOOK VALUE |
| At 31 December 2025 | 10,418 | 227,346 | 4,208,674 |
| At 31 December 2024 | 14,207 | 168,300 | 4,961,156 |
| 12. | FIXED ASSET INVESTMENTS |
| Company |
| Shares in |
| group |
| undertakings |
| £ |
| COST |
| At 1 January 2025 |
| and 31 December 2025 |
| NET BOOK VALUE |
| At 31 December 2025 |
| At 31 December 2024 |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 12. | FIXED ASSET INVESTMENTS - continued |
| The group or the company's investments at the Balance Sheet date in the share capital of companies include the following: |
| Subsidiaries |
| Registered office: United Kingdom |
| Nature of business: |
| % |
| Class of shares: | holding |
| 2025 | 2024 |
| £ | £ |
| Aggregate capital and reserves |
| Profit for the year |
| Registered office: Japan |
| Nature of business: |
| % |
| Class of shares: | holding |
| 2025 | 2024 |
| £ | £ |
| Aggregate capital and reserves | ( |
) | ( |
) |
| Loss for the year | ( |
) | ( |
) |
| Registered office: United Kingdom |
| Nature of business: |
| % |
| Class of shares: | holding |
| 2025 | 2024 |
| £ | £ |
| Aggregate capital and reserves |
| Registered office: China |
| Nature of business: |
| % |
| Class of shares: | holding |
| 2025 | 2024 |
| £ | £ |
| Aggregate capital and reserves | ( |
) | ( |
) |
| Profit/(loss) for the year | ( |
) |
| Registered office: China |
| Nature of business: |
| % |
| Class of shares: | holding |
| 2025 | 2024 |
| £ | £ |
| Aggregate capital and reserves |
| Loss for the year | ( |
) | ( |
) |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 12. | FIXED ASSET INVESTMENTS - continued |
| Registered office: United States of America |
| Nature of business: |
| % |
| Class of shares: | holding |
| - |
| 2025 | 2024 |
| £ | £ |
| Aggregate capital and reserves | ( |
) | ( |
) |
| Loss for the year | ( |
) | ( |
) |
| The company was setup in the state of Delaware with iPulse Limited owning 100% of the 100 shares of common stock, $0.001 par value. |
| MC500 Limited |
| Registered office: United Kingdom |
| Nature of business: Dormant |
| % |
| Class of shares: | holding |
| Ordinary | 100.00 |
| 2025 | 2024 |
| £ | £ |
| Aggregate capital and reserves | 1 | 1 |
| All subsidiaries have been included in the consolidated financial statements. |
| 13. | STOCKS |
| Group |
| 2025 | 2024 |
| £ | £ |
| Stocks | 19,018,819 | 14,695,104 |
| Work-in-progress | 75,907 | 806,027 |
| Finished goods | 1,874,005 | 2,177,261 |
| 20,968,731 | 17,678,392 |
| 14. | DEBTORS |
| Group | Company |
| 2025 | 2024 | 2025 | 2024 |
| £ | £ | £ | £ |
| Amounts falling due within one year: |
| Trade debtors | 16,460,402 | 11,297,683 |
| Amounts owed by group undertakings | - | - |
| Other debtors | 1,267,206 | 284,233 |
| VAT | - | 534,555 |
| Deferred tax asset | 536,104 | 1,095,121 | - | - |
| Prepayments | 1,679,939 | 706,929 |
| 19,943,651 | 13,918,521 |
| Amounts falling due after more than one | year: |
| Prepayments and accrued income | 883 | 11,794 |
| Aggregate amounts | 19,944,534 | 13,930,315 |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 14. | DEBTORS - continued |
| Deferred tax asset |
| Group | Company |
| 2025 | 2024 | 2025 | 2024 |
| £ | £ | £ | £ |
| Deferred tax | 536,104 | 1,095,121 | - | - |
| Group balances are repayable on demand, however the directors believe that the amount will be repaid over more than one year. |
| 15. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| Group | Company |
| 2025 | 2024 | 2025 | 2024 |
| £ | £ | £ | £ |
| Trade creditors | 10,832,135 | 9,856,411 |
| Amounts owed to group undertakings | - | - |
| Tax | (331 | ) | 405 |
| Social security and other taxes | 326,110 | 250,755 |
| VAT | 2,107,817 | - | - | - |
| Other creditors | 2,766,935 | 2,473,239 |
| Deferred income | 1,087,262 | 1,609,515 |
| Accrued expenses | 2,116,967 | 1,814,667 |
| 19,236,895 | 16,004,992 |
| 16. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |
| Group |
| 2025 | 2024 |
| £ | £ |
| Accruals and deferred income | 743,714 | 492,859 |
| 17. | LEASING AGREEMENTS |
| Minimum lease payments fall due as follows: |
| Group |
| Non-cancellable |
| operating leases |
| 2025 | 2024 |
| £ | £ |
| Within one year | 977,563 | 1,012,303 |
| Between one and five years | 3,991,044 | 2,410,152 |
| In more than five years | 1,448,030 | 680,875 |
| 6,416,637 | 4,103,330 |
| 18. | PROVISIONS FOR LIABILITIES |
| Group |
| 2025 | 2024 |
| £ | £ |
| Other provisions | 619,224 | 315,370 |
| Aggregate amounts | 619,224 | 315,370 |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 18. | PROVISIONS FOR LIABILITIES - continued |
| Group |
| Deferred | Warranty |
| tax | &liabilityprovision |
| £ | £ |
| Balance at 1 January 2025 | (1,095,121 | ) | 315,370 |
| Provided during year | 559,017 | 303,854 |
| Balance at 31 December 2025 | (536,104 | ) | 619,224 |
| Other provisions represent warranty and liability claims. Warranty costs run over a two to five year period from the point of sale and are utilised on expiry of the period. The credit to the profit and loss is the net affect of provisions relating to current year sales, warranty costs incurred in the year and the release of expired warranties. |
| Deferred tax assets and liabilities are offset where the company has a legally enforceable right to do so. The following analysis is the analysis of the deferred tax balances (after offset) for financial reporting purposes: |
| 2025 | 2024 |
| Net Asset | Net Asset |
| Balances: | £ | £ |
| ACAs | 368,931 | 595,203 |
| Tax losses | (905,035 | ) | (1,690,324 | ) |
| (536,104 | ) | (1,095,121 | ) |
| The deferred tax asset is recognised as it is considered probable that future taxable profits will be available against which the unused tax losses will be utilised. |
| 19. | CALLED UP SHARE CAPITAL |
| Allotted and issued: |
| Number: | Class: | Nominal | 2025 | 2024 |
| value: | £ | £ |
| 52,360,980 | Ordinary | 0.001p | 52,361 | 52,211 |
| Each share is entitled to: |
| - One vote in any circumstances; |
| - Pari passu to dividend or any other distribution; and |
| - full participation in capital distributions. |
| 20. | RESERVES |
| Group |
| Capital |
| Retained | Share | redemption |
| earnings | premium | reserve |
| £ | £ | £ |
| At 1 January 2025 | 21,510,144 | 1,398,966 | 1,719 |
| Profit for the year | 5,491,046 |
| At 31 December 2025 | 27,001,190 | 1,398,966 | 1,719 |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 20. | RESERVES - continued |
| Group |
| Share |
| option | EBT |
| reserve | reserve | Totals |
| £ | £ | £ |
| At 1 January 2025 | 617,409 | (1,075,000 | ) | 22,453,238 |
| Profit for the year | 5,491,046 |
| Share option fair value | (115,564 | ) | - | (115,564 | ) |
| At 31 December 2025 | 501,845 | (1,075,000 | ) | 27,828,720 |
| Company |
| Capital |
| Retained | Share | redemption |
| earnings | premium | reserve |
| £ | £ | £ |
| At 1 January 2025 |
| Profit for the year |
| At 31 December 2025 |
| Company |
| Share |
| option | EBT |
| reserve | reserve | Totals |
| £ | £ | £ |
| At 1 January 2025 | ( |
) | 4,423,129 |
| Profit for the year |
| Share option fair value | (115,564 | ) | - | (115,564 | ) |
| At 31 December 2025 | ( |
) | 4,398,337 |
| Called up share capital - represents the nominal value of shares that have been issued. |
| Share Premium - represents the premium above the nominal value of shares that have been issued. |
| Capital redemption reserve - represents payments to acquire own shares. |
| Share option reserve - represents the fair value of share options granted to employees. |
| Retained earnings - included all current and prior period retained profits and losses. |
| EBT Reserve - Represents the consideration paid for ordinary shares by iPulse Employee Benefit Trust. |
| At the year end iPulse Employee Benefit Trust held 500,000 (2024: 500,000) ordinary 0.001p shares of iPulse Limited. |
| During the year, 2.97m shares were issued with a nominal value of £0.001 per share. |
| 21. | CAPITAL COMMITMENTS |
| 2025 | 2024 |
| £ | £ |
| Contracted but not provided for in the |
| financial statements | 289,406 | - |
| IPULSE LIMITED (REGISTERED NUMBER: 08306196) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 22. | RELATED PARTY DISCLOSURES |
| During the year the group paid £2,202,888 (2024: £2,017,273) to key management personnel. |
| During the year the group undertook transactions in the form of consultancy work totalling £109,667 (2024 - £115,835) and had balances of £4,000 (2024 - £18,926) outstanding at the year end, with directors or companies which the directors are connected. |
| 23. | POST BALANCE SHEET EVENTS |
| There were no events after the reporting period to the date the accounts were approved that are material for disclosure in the financial statements. |
| 24. | ULTIMATE CONTROLLING PARTY |
| Richard Koch is the ultimate controlling party by virtue of holding more than 50% of the iPulse Limited share capital. |
| 25. | SHARE-BASED PAYMENT TRANSACTIONS |
| Share Options |
| At the year end 257,550 options were available to exercise by 7 individuals, of which 6 are current directors and employees of the company. |
| Options have been granted on varying dates as shown in the table below: |
| No of options |
No of individuals |
Grant date |
Option life |
Exercise price |
| 20,000 | 1 | 11/06/13 | No termination date | £1.00 |
| 137,550 | 4 | 25/03/20 | 10 years | £2.15 |
| 100,000 | 1 | 08/12/20 | 10 years | £3.00 |
| There are no exercise conditions attached to these options. |